Cytek Biosciences (CTKB) Stock Insights

CTKB price $6.08 +0.10 +1.59%

Ticker
CTKB
Price
$6.08
Change
+0.10 +1.59%
Market cap ?
$789.65M
Beta ?
1.16
Sector
Healthcare
Industry
Medical - Devices

Fair value

CTKB fair value $2.22. Price $6.08. Price is 174% above fair value.

Above fair value, and more expensive than usual. A larger premium than on more than 99% of days in the past 5 years.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Calculated with a 10-year free-cash-flow discount. Starting free cash flow 29.54M. Growth 3.82%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 10.68% (beta 1.2). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 129.98M. Net debt -67.11M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.

Model uncertainty high for this stock

Compare CTKB

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-04—-0.07—53.05M
2026-08-05-0.05-0.0948.14M47.31M
2026-05-07-0.12-0.0844.13M44.23M
2026-02-26-0.34-0.0262.14M57.15M
2025-11-05-0.01-0.0352.29M51.21M
2025-08-06-0.04-0.0245.60M46.34M
2025-05-08-0.09-0.0441.46M42.66M
2025-02-270.070.0557.48M59.38M
2024-11-050.01-0.0151.50M50.70M
2024-08-06-0.08-0.0346.62M49.53M
2024-05-08-0.05-0.0444.86M43.59M
2024-02-280.070.0358.60M56.58M
2023-11-070.010.0348.00M55.48M
2023-08-080.010.0349.69M45.71M
2023-05-09-0.050.0337.09M47.15M
2023-02-280.060.0548.30M50.22M
2022-11-090.040.0240.48M43.29M
2022-08-100.030.0240.16M39.63M
2022-05-110.010.0135.06M32.51M
2022-02-230.050.0338.90M36.42M
2021-11-080.020.0234.38M30.41M
2021-09-020.020.0230.41M28.27M
2021-07-270.00—24.27M—
2020-12-310.05—30.62M—
2020-09-300.18—25.10M—
2020-06-300.23—19.14M—
2020-03-31-0.01—17.99M—

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-08-18Jiang WenbinBuy57.21K——
2026-08-18Jiang WenbinSell20.96K$4.6797.86K
2026-08-18Jiang WenbinBuy29.00K——
2026-08-18Jiang WenbinSell7.06K$4.6732.98K
2026-08-18Jiang WenbinBuy22.10K——
2026-08-18Jiang WenbinSell5.38K$4.6725.13K
2026-08-18Jiang WenbinBuy11.78K——
2026-08-18Jiang WenbinSell2.87K$4.6713.40K
2026-08-18Jiang WenbinSell57.21K——
2026-08-18Jiang WenbinSell29.00K——
2026-08-18Jiang WenbinSell22.10K——
2026-08-18Jiang WenbinSell11.78K——
2026-08-18McCombe William D.Sell16.05K——
2026-08-18McCombe William D.Buy16.05K——
2026-08-18McCombe William D.Sell13.05K——
2026-08-18McCombe William D.Sell5.40K$4.6725.22K
2026-08-18McCombe William D.Buy13.05K——
2026-08-18McCombe William D.Sell4.39K$4.6720.51K
2026-08-18McCombe William D.Buy6.32K——
2026-08-18McCombe William D.Sell2.11K$4.679.86K
2026-08-18McCombe William D.Sell6.32K——
2026-08-18MUIR GLENN PSell3.09K——
2026-08-18MUIR GLENN PBuy3.09K——
2026-08-18Holder MichaelBuy2.18K——
2026-08-18Holder MichaelSell2.18K——
2026-08-18Chin RichardSell6.11K——
2026-08-18Chin RichardBuy6.11K——
2026-08-18Yan MingBuy14.22K——
2026-08-18Yan MingSell3.46K$4.6716.17K
2026-08-18Yan MingBuy6.16K——
2026-08-18Yan MingSell1.50K$4.677.01K
2026-08-18Yan MingBuy5.53K——
2026-08-18Yan MingSell1.35K$4.676.29K
2026-08-18Yan MingBuy7.36K——
2026-08-18Yan MingSell1.78K$4.678.30K
2026-08-18Yan MingSell14.22K——
2026-08-18Yan MingSell6.16K——
2026-08-18Yan MingSell5.53K——
2026-08-18Yan MingSell7.36K——
2026-08-10Feuchtwang IlanBuy241.42K——
2026-08-10Feuchtwang IlanBuy127.12K$4.66592.37K
2026-06-29Feuchtwang IlanOther0——
2026-06-12Yan MingSell135.89K——
2026-06-10Ball JackBuy43.97K——
2026-06-10Ball JackSell43.97K——
2026-06-10MUIR GLENN PBuy55.55K——
2026-06-10MUIR GLENN PBuy29.84K$4.05120.83K
2026-06-10MUIR GLENN POther0——
2026-06-10Chin RichardBuy33.33K——
2026-06-10Chin RichardBuy18.26K$4.0573.96K
2026-06-10Imper VeraBuy43.97K——
2026-06-10Imper VeraBuy33.33K——
2026-06-10Imper VeraBuy18.26K$4.0573.96K
2026-06-10Imper VeraSell43.97K——
2026-06-10NEFF DEBORAH JBuy43.97K——
2026-06-10NEFF DEBORAH JBuy33.33K——
2026-06-10NEFF DEBORAH JBuy18.26K$4.0573.96K
2026-06-10NEFF DEBORAH JSell43.97K——
2026-06-10Holder MichaelBuy43.97K——
2026-06-10Holder MichaelBuy33.33K——
2026-06-10Holder MichaelBuy18.26K$4.0573.96K
2026-06-10Holder MichaelSell43.97K——
2026-05-18Holder MichaelBuy1.45K——
2026-05-18Holder MichaelSell1.45K——
2026-05-18Chin RichardSell6.11K——
2026-05-18Chin RichardBuy6.11K——
2026-05-18Yan MingBuy9.48K——
2026-05-18Yan MingSell2.36K$3.558.39K
2026-05-18Yan MingBuy4.11K——
2026-05-18Yan MingSell1.02K$3.553.64K
2026-05-18Yan MingBuy3.68K——
2026-05-18Yan MingSell919$3.553.26K
2026-05-18Yan MingBuy4.91K——
2026-05-18Yan MingSell1.22K$3.554.35K
2026-05-18Yan MingSell9.48K——
2026-05-18Yan MingSell4.11K——
2026-05-18Yan MingSell3.68K——
2026-05-18Yan MingSell4.91K——
2026-05-18Busque PhilippeSell5.55K——
2026-05-18Busque PhilippeBuy5.55K——
2026-05-18Busque PhilippeSell1.42K$3.555.06K
2026-05-18Busque PhilippeSell2.42K——
2026-05-18Busque PhilippeBuy2.42K——
2026-05-18Busque PhilippeSell620$3.552.20K
2026-05-18Busque PhilippeBuy1.47K——
2026-05-18Busque PhilippeSell378$3.551.34K
2026-05-18Busque PhilippeBuy1.02K——
2026-05-18Busque PhilippeSell263$3.55934
2026-05-18Busque PhilippeSell1.47K——
2026-05-18Busque PhilippeSell1.02K——
2026-05-18Jiang WenbinBuy38.14K——
2026-05-18Jiang WenbinSell15.01K$3.5553.28K
2026-05-18Jiang WenbinBuy19.33K——
2026-05-18Jiang WenbinSell5.03K$3.5517.86K
2026-05-18Jiang WenbinBuy14.73K——
2026-05-18Jiang WenbinSell3.59K$3.5512.74K
2026-05-18Jiang WenbinBuy7.85K——
2026-05-18Jiang WenbinSell1.91K$3.556.79K
2026-05-18Jiang WenbinSell38.14K——
2026-05-18Jiang WenbinSell19.33K——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 156, holders -9 vs prior quarter. Ownership 63.84%.

HolderSharesChangeChange %Value
BLACKROCK, INC.9.58M-7.43M-43.68%42.43M
MILLENNIUM MANAGEMENT LLC9.34M3.05M+48.42%41.37M
BOSTON PARTNERS7.66M1.86M+32.02%33.94M
HHLR ADVISORS, LTD.6.66M00.00%29.49M
TOPLINE CAPITAL MANAGEMENT, LLC6.28M-781.03K-11.06%27.84M
VANGUARD CAPITAL MANAGEMENT LLC4.94M176.69K+3.71%21.88M
GEODE CAPITAL MANAGEMENT, LLC3.06M225.62K+7.96%13.56M
DIMENSIONAL FUND ADVISORS LP2.62M-47.07K-1.77%11.59M
STATE STREET CORP2.57M-1.56M-37.77%11.37M
GOLDMAN SACHS GROUP INC2.17M-177.22K-7.56%9.60M
ROYCE & ASSOCIATES LP2.08M439.21K+26.74%9.22M
RUSSELL INVESTMENTS GROUP, LTD.1.51M151.41K+11.13%6.70M
ACADIAN ASSET MANAGEMENT LLC1.38M977.06K+244.88%6.09M
BANK OF AMERICA CORP /DE/1.32M306.28K+30.35%5.83M
VANGUARD PORTFOLIO MANAGEMENT LLC1.14M-1.17M-50.62%5.06M
CHARLES SCHWAB INVESTMENT MANAGEMENT INC1.07M-31.35K-2.84%4.75M
SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P.1.07M1.07MNew4.75M
NORTHERN TRUST CORP1.00M-1.90K-0.19%4.44M
HRT FINANCIAL LP997.77K583.72K+140.98%4.42M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP973.83K653.92K+204.41%4.31M
JANE STREET GROUP, LLC906.16K906.16KNew4.01M
TUDOR INVESTMENT CORP ET AL837.91K517.20K+161.26%3.71M
AQR CAPITAL MANAGEMENT LLC813.97K-98.37K-10.78%3.61M
VANGUARD FIDUCIARY TRUST CO740.66K23.65K+3.30%3.28M
CITADEL ADVISORS LLC721.47K250.08K+53.05%3.20M

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Cytek Biosciences (CTKB) Stock Insights

CTKB$6.08+0.10 +1.59%

$789.65M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History